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The nuclear factor of activated T cells (NFAT) proteins
 
are a family of transcription factors whose activation is
 
controlled by calcineurin, a Ca
 
2
 
 
 
-dependent phosphatase.
Originally identiﬁed in T cells as inducers of cytokine gene
 
expression, NFAT proteins play varied roles in cells outside
of the immune system. This review addresses the recent
data implicating NFAT in the control of gene expression
inﬂuencing the development and adaptation of numerous
mammalian cell types.
 
The formation and function of tissues requires the acquisition
 
of cellular phenotype during differentiation. Differentiation
involves expression of genes that specify cellular fate and
down-regulation of genes that hold cells in a pluripotent
state. Once a tissue forms, changes in gene expression are
also important as cells within a tissue adapt to environmental
changes through a pattern of new protein expression. These
cellular adaptations allow cells within a tissue to survive and
 
maintain function. Thus, the control of gene expression is
important for the formation, function, and maintenance
of tissues.
 
Regulation of gene expression occurs through a variety
 
of signaling pathways. Calcineurin is a Ca
 
2
 
 
 
/calmodulin-
dependent protein phosphatase that is a downstream target
 
of intracellular Ca
 
2
 
 
 
 signaling (Rusnak and Mertz, 2000).
The best-characterized substrate of calcineurin is the NFAT*
 
family of transcription factors (NFATC1–C4) (Rao et
al., 1997). During periods of sustained elevations of cal-
cium, calcineurin dephosphorylates NFATC1–C4, allowing
 
NFAT to translocate to the nucleus. This nuclear translocation
is blocked by cyclosporine A (CSA), which blocks calcineurin
activity. Once in the nucleus, NFAT binds to consensus
DNA sites and controls gene transcription. Upon cessation
of the Ca
 
2
 
 
 
 signal, termination of NFAT signaling occurs
through rephosphorylation of NFAT by kinases such as
GSK-3 (Graef et al., 2001b), resulting in its translocation to
the cytoplasm.
Initially, different NFAT family members were considered
to have redundant functions but now are known to have
distinct roles in cellular physiology. The varied expression
profiles among cell types provided the first clue to functional
nonredundancy (Rao et al., 1997). Further evidence was
provided by activation of specific isoforms even when multi-
 
ple isoforms are expressed within a cell. For example, in T cells
and skeletal muscle cells, different NFAT isoforms translocate
to the nucleus at specific stages of differentiation in response
 
to a Ca
 
2
 
 
 
 signal (Abbott et al., 1998; Adachi et al., 2000). The
examples discussed below provide evidence for distinct
functions of individual NFAT isoforms in the development
and adaptation of a wide range of cell types (Tables 1 and 2).
 
NFAT regulates cell differentiation and development
 
NFAT signaling controls multiple steps in the development
of the cardiovascular system. In the embryonic heart,
NFATC1 is initially expressed broadly, but by E11.5 becomes
restricted to cells that will eventually form the heart valves.
 
NFATC1
 
 
 
/
 
 
 
 mice have defective heart valve development
and abnormalities in the cardiac septum (de la Pompa et
al., 1998; Ranger et al., 1998). The signals that regulate
NFATC1 expression and the downstream gene targets of
NFATC1 clearly function to pattern heart organization
during development.
NFAT also regulates peripheral vascular development
during angiogenesis. Angiogenesis is a multistep process that
involves cellular proliferation, differentiation, and migration
of both endothelial cells and vascular smooth muscle cells
(VSMCs) to give rise to mature blood vessels. During em-
bryogenesis, NFATC3 and NFATC4 are expressed in
perivascular tissues that direct the developing endothelial
cells and VSMCs. NFATC3/C4 double null mice display
disorganization of blood vessels and poor vessel wall integ-
rity, leading to early embryonic lethality (Graef et al.,
2001a). Dissection of the genes regulated by NFATC3 and
NFATC4 will elucidate how tissue interactions occur to give
rise to the peripheral vascular system.
NFAT signaling is also important in endothelial cells in
response to vascular endothelial growth factor (VEGF).
 
Address correspondence to Dr. G. Pavlath, Emory University School of
 
Medicine, Department of Pharmacology, Room 5027, O.W. Rollins
Research Building, Atlanta, GA 30322. Tel.: (404) 727-3353. Fax: (404)
727-0365. E-mail: gpavlat@emory.edu
*Abbreviations used in this paper: COX, cyclooxygenase; CSA, cyclospo-
rine A; ISMC, ileal smooth muscle cell; MyHC, myosin heavy chain;
NFAT, nuclear factor of activated T cells; PDGF, platelet-derived
growth factor; VEGF, vascular endothelial growth factor; VSMC, vascu-
lar smooth muscle cell.
Key words: NFAT; development; adaptation; calcium signaling; cell fate 
772 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 5, 2002
 
VEGF treatment results in translocation of NFATC2 to the
nucleus of primary endothelial cells (Armesilla et al., 1999).
Once in the nucleus, NFATC2 binds to the promoter of cy-
clooxygenase (COX)2, a key enzyme in prostaglandin syn-
thesis, and activates transcription (Hernandez et al., 2001).
The production of prostaglandins downstream of NFAT
signaling is necessary for the migration of endothelial cells to
allow the proper formation of endothelial tubes and an-
giogenesis to occur in vivo. This function of NFATC2 in
endothelial cell migration appears to be postnatal since
 
NFATC2
 
 
 
/
 
 
 
 
 
mice are viable with no reported developmen-
tal defects in angiogenesis.
The musculoskeletal system is also dependent on NFAT
signaling. Skeletal muscle tissue forms from the prolifera-
tion, differentiation, and fusion of muscle precursor cells to
form multinucleated muscle cells. NFATC3
 
 
 
/
 
 
 
 mice have
embryonic defects in the formation of primary myofibers,
the first multinucleated muscle cell (Kegley et al., 2001).
NFATC2 plays a role in the postnatal growth of skeletal
muscle. NFATC2
 
 
 
/
 
 
 
 mice form small multinucleated mus-
 
Table I. 
 
Evidence for the role of NFAT isoforms in the development of numerous cell types
Tissue/cell type NFAT isoform 
implicated 
Methods used to 
determine role for NFAT
Target gene Function References
 
Heart NFATC1 NFATC1
 
 
 
/
 
 
 
 mice ? Development of heart valve de la Pompa et al., 1998; 
Ranger et al., 1998
Vascular endothelial 
cells (primary cells)
NFATC2 EMSA and reporter 
assays
 
1
 
; PG rescue of 
CSA effect in vitro/in vivo
COX2 VEGF signaling; 
PG synthesis during 
angiogenesis
Armesilla et al., 1999; 
Hernandez et al., 2001
Perivascular tissue NFATC3/C4 NFATC3/C4 double 
null mice
? Organization of developing 
blood vessels
Graef et al., 2001a
Skeletal  muscle 
reserve cells
NFATC1 Overexpression and 
inhibition of NFAT in 
primary muscle cultures
myf-5 Expression of myf5 Friday and Pavlath, 2001
Skeletal muscle 
myotubes
NFATC2 NFATC2
 
 
 
/
 
 
 
 mice ? Skeletal muscle growth Horsley et al., 2001
Skeletal muscle 
myoblasts
NFATC3 NFATC3
 
 
 
/
 
 
 
 mice ? Formation of primary myofibers Kegley et al.,  2001
Chondrocytes NFATC2 NFATC2
 
 
 
/
 
 
 
 mice  ? Inhibition of chondrogenesis Ranger et al., 2000
Keratinocytes 
(primary cells)
NFATC3 Reporter assays
 
2
 
; NFAT 
inhibition; CSA treatment
p21
 
WAF1/CIP
 
Activation of p21 
during differentiation
Santini et al., 2001
Adipocytes (cell line) NFATC2/C4 EMSA and reporter 
assays
 
3
 
; CSA treatment
aP2 Expression of adipocyte 
specific genes during 
differentiation
Ho et al., 1998
PG, prostaglandin.
 
1
 
COX2 promoter construct.
 
2
 
NFAT reporter and p21 promoter constructs.
 
3
 
aP2 promoter construct.
Table II. 
 
Evidence for the role of NFAT in cellular adaptation
Cell type NFAT isoform 
implicated 
Methods used to 
determine role for NFAT
Target gene Function References
 
Pancreatic islet cells 
(cell line)
NFATC2 EMSA and reporter assays
 
1
 
Glucagon Expression of glucagon Furstenau et al., 1999
Epidermal cell 
(cell line)
? Reporter assays
 
2
 
 in vitro 
and in vivo
? Response to UV radiation Huang et al., 2000
Cardiac muscle NFATC4 Overexpression in 
transgenic mice
? Cardiac hypertrophy Molkentin et al., 1998
Skeletal myofibers 
(in vitro)
NFATC1 Nuclear localization ? Response to nerve stimuli  Liu et al., 2001
Skeletal muscle cells 
(cell line)
? Reporter assays
 
3
 
MyHC II Expression of MyHC II isoforms Allen et al., 2001
VSMCs 
(primary cells)
NFATC1/C2 Reporter assays
 
4
 
? Agonist induced signaling Boss et al., 1998
ISMCs 
(isolated tissue)
NFATC3 Nuclear localization; 
reporter assays
 
5
 
? Response to PDGF Stevenson et al., 2001
EMSA, electrophoretic mobility shift assay.
 
1
 
Glucagon promoter constructs.
 
2
 
NFAT reporter construct; NFAT-luciferase transgenic mice.
 
3
 
MyHC II promoter constructs.
 
4
 
NFAT reporter construct.
 
5
 
NFAT-luciferase transgenic mice. 
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cle cells due to a defect in the recruitment and/or fusion of
myogenic cells with nascent multinucleated muscle cells
(Horsley et al., 2001). In addition, NFAT may regulate a
subpopulation of myogenic cells called reserve cells. These
cells remain unfused in cultures of multinucleated muscle
cells and express the muscle regulatory protein, myf-5.
NFATC1 enhances the expression of myf-5 in these cells,
suggesting that NFAT may regulate properties of reserve
cells (Friday and Pavlath, 2001). Thus, NFAT has distinct
functions in multiple steps of myogenesis.
Cartilage formation in the adult is critical for the move-
ment of joints and is often disrupted in osteoarthritis. The
differentiation of adult mesenchymal stem cells into carti-
lage forming cells is associated with NFATC2 up-regulation
(Ranger et al., 2000). Older NFATC2
 
 
 
/
 
 
 
 mice have im-
paired ambulation and decreased joint motion, resulting
from excess cartilage formation due to increased chondro-
cyte cell proliferation and differentiation. In adult chondro-
cytes, NFATC2 acts as a negative regulator to promote the
appropriate formation of cartilage within adult joints.
The structure and function of the epidermis depends on
the balance between proliferation and differentiation of kera-
tinocytes. Differentiation of primary keratinocyte cells in
vitro is associated with nuclear localization of NFAT and
blocked by CSA (Santini et al., 2001). As keratinocytes dif-
ferentiate, cell cycle withdrawal is induced by expression of
p21
 
WAF1/CIP1
 
, an inhibitor of cyclin-dependent kinases. Acti-
vation of p21 expression is dependent on a calcineurin-
induced physical association of NFAT with Sp1/Sp3. Thus,
an NFAT-Sp1/Sp3 signaling pathway is required for kerati-
nocyte differentiation in vitro. Further work is needed to de-
termine whether NFAT regulates such differentiation in vivo.
NFAT proteins also appears to regulate adipocyte differ-
entiation in vitro (Ho et al., 1998). During fat cell forma-
tion, a population of uncommited mesodermal precursor
cells are induced to express adipocyte specific genes such as
fatty acid binding protein and aP2. A role for NFAT is sug-
gested by the fact that NFATC2 and NFATC4 bind to the
promoter of aP2 in differentiated 3T3-L1 adipocytes. Fur-
thermore, CSA blocks adipocyte differentiation. More stud-
ies are needed to conclusively show that NFAT signaling
regulates adipogenesis both in vitro and in vivo.
 
Role of NFAT in cell adaptation
 
Cellular adaptation in response to environmental changes al-
lows tissue function and survival. NFAT has recently been
implicated in the adaptation of numerous cell types in re-
sponse to external stimuli from the environment (Table II).
Glucagon is an important regulator of blood glucose levels by
stimulating either glycogenolysis or gluconeogenesis in the liver.
Glucagon synthesis in pancreatic islet cell lines is regulated by
multiple calcium pathways including NFAT (Furstenau et al.,
1999). Upon membrane depolarization, NFATC2 translocates
to the nucleus, binds to the glucagon promoter together with
the transcription factor HNF-3
 
 
 
, and activates transcription. If
these results are verified in vivo, NFAT signaling in pancreatic
cells may be critical for blood glucose homeostasis.
Mammalian cells respond to UV radiation by activating
signal transduction pathways in a process known as the “UV
response.” This UV response elicits a number of biological
 
effects in skin to protect the epidermis from DNA damage.
NFAT-mediated transcription is induced in epidermal cells
in response to UV radiation in both epidermal cell lines and
in skin in vivo (Huang et al., 2000). Thus, NFAT proteins
likely regulate adaptation in the epidermis following expo-
sure to UV radiation.
NFAT may also regulate the adaptive responses of all mus-
cle cell types in the body. Hypertrophy of cardiac and skeletal
muscle cells occurs in response to increased workload and var-
ious agonists. Cardiac specific expression of a constitutively
active calcineurin or NFATC4 in transgenic mice is sufficient
to induce cardiac hypertrophy (Molkentin et al., 1998).
Whether calcineurin signaling is involved in all forms of car-
diac hypertrophy is controversial (Leinwand, 2001). A role for
calcineurin and NFAT in skeletal muscle hypertrophy is also
not without controversy (Bodine et al., 2001; Rommel et al.,
2001). CSA inhibits overload induced hypertrophy in skeletal
muscle, suggesting a role for calcineurin, but whether NFAT
is a downstream mediator is unknown (Dunn et al., 1999).
IGF-1 induces muscle cell hypertrophy and nuclear transloca-
tion of NFATC1 in vitro (Musaro et al., 1999). Further work
is required to determine if NFAT signaling is directly involved
in cardiac and skeletal muscle hypertrophy.
In response to motor neuron activity, distinct patterns of
gene expression are activated in skeletal muscle fibers, lead-
ing to slow and fast twitch myofibers. These subtypes are
characterized by expression of different isoforms of myosin
heavy chain (MyHC). A proposed role for calcineurin in
slow myofiber gene expression (Olson and Williams, 2000;
Serrano et al., 2001) has been debated (Calvo et al., 1999;
Swoap et al., 2000). The studies by Liu et al. demonstrate
that patterns of electrical stimulation characteristic of slow
motor neurons induce nuclear translocation of NFATC1 in
isolated myofibers (Liu et al., 2001). This evidence is the
first link between activation of NFAT and a physiologic
stimulus in myofibers. Recent data suggest that NFAT may
regulate not only slow but fast myofiber phenotype. Cal-
cineurin activation of the fast MyHC IIa promoter requires
NFAT consensus sequences (Allen et al., 2001), but consti-
tutively active NFAT down-regulates transcription of fast
MyHC type IIb and IIx/d promoters. These data contribute
to the complexity of calcineurin and NFAT signaling in
skeletal muscle physiology.
Smooth muscle cells also utilize NFAT signaling for adapta-
tion. In response to extracellular signals, smooth muscle cells
alter gene expression, remodel their extracellular matrix, and
begin cell proliferation and migration. NFAT proteins are ex-
pressed in VSMCs in culture (Boss et al., 1998), and in native
ileal smooth muscle cells (ISMCs) (Stevenson et al., 2001). In
response to platelet-derived growth factor (PDGF), NFAT-
mediated transcription occurs in both ISMCs and VSMCs.
Since PDGF is an important smooth muscle mitogen, these
data suggest that activation of NFAT may be involved in
smooth muscle cell adaptation. These examples illustrate that
NFAT-regulated gene transcription may be a common signal-
ing mechanism in cardiac, skeletal, and smooth muscle cells.
 
Future perspectives
 
The identification of NFAT in nonimmune cells has led to re-
cent data implicating this family of transcription factors in the 
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development and adaptation of multiple cell types. Future
challenges in the field include corroborating results obtained
in cell culture to that in native tissues as well as determining
whether NFAT regulates the expression of endogenous target
genes or occupies endogenous promoters in vivo. Additionally,
the upstream receptor–ligand interactions that lead to activa-
tion of NFAT are not well characterized in many cell types.
Furthermore, many of the transcription factors that work in
synergy with NFAT are unknown. Defining the upstream
ligands and receptors, transcriptional partners and genes regu-
lated by NFAT signal transduction pathways will elucidate
how development and adaptation occurs in multiple cell types.
Manipulation of the cellular responses regulated by NFAT
may be clinically relevant in nonimmune cells. The cur-
rently available drugs, such as CSA and FK506, both inhibit
calcineurin activity and thus inhibit NFAT signaling indi-
rectly. Manipulating NFAT pathways to treat disease will be
facilitated by drugs that directly inhibit NFAT activation
without affecting calcineurin activity toward other sub-
strates. Such NFAT specific inhibitors would likely decrease
the number of side effects associated with current therapies
that inhibit calcineurin-dependent pathways. Utilization of
upstream activators of NFAT signaling may also aid in dis-
ease treatment. Further study of the biology of NFAT sig-
naling in a range of cell types will facilitate the manipulation
of these pathways to treat disease.
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